In addition, the same authors identified a molecular signature, comprising also EFNA1, PTPN12, ATF2 and mir-26b and mir-200, that was of prognostic significance in patients with stage I–III CRC and proposed it as a novel CRC prognostic biomarker [50]. Here, EFNA1 is linked to colorectal carcinoma.